Changes of Serum Cytokines in Hyperthyroid Graves’ Disease Patients at Diagnosis and during Methimazole Treatment

Publisher： Karger

E-ISSN： 1423-0216|18|1|45-51

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.18, Iss.1, 2010-07, pp. : 45-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Correlation between Serum Osteoprotegerin and Biomarkers of Bone Metabolism during Anti-Thyroid Treatment in Patients with Graves’ Disease

By  

Hormone Research in Paediatrics, Vol. 66, Iss. 5, 2006-10 ,pp. : 236-239

Karger

Access to resources Recommend Favorite

Treatment of Graves’ Disease in Children and Adolescents

By  

Hormone Research in Paediatrics, Vol. 49, Iss. 6, 1998-05 ,pp. : 255-257

Karger

Access to resources Recommend Favorite

Neither Baseline nor Changes in Serum Triiodothyronine during Levothyroxine/Liothyronine Combination Therapy Predict a Positive Response to This Treatment Modality in Hypothyroid Patients with Persistent Symptoms

By  

European Thyroid Journal, Vol. 6, Iss. 2, 2017-01 ,pp. : 89-93

Karger

Access to resources Recommend Favorite

Pre-Operative Lugol's Iodine Treatment in the Management of Patients Undergoing Thyroidectomy for Graves' Disease: A Review of the Literature

By  

European Thyroid Journal, Vol. 6, Iss. 1, 2016-11 ,pp. : 20-25

Karger

Access to resources Recommend Favorite

Th1 and Th2 Serum Cytokine Profiles Characterize Patients with Hashimoto’s Thyroiditis (Th1) and Graves’ Disease (Th2)

By  

Neuroimmunomodulation, Vol. 11, Iss. 4, 2004-07 ,pp. : 209-213

Karger

Access to resources Recommend Favorite